Biodegradeable gene vector launched
Japan's Nitto Denko has developed what it claims is the world's
first biodegradable gene carrier that can be used to transfer
foreign genes into animal cells. Because the polymer breaks down in
the body, it exhibits extremely...
Scientists create tools to make life from scratch
Researchers in the US say they have achieved a critical objective
in an effort to create a living organism from DNA building-blocks.
The process used could be used to create bespoke cell-based
organisms to carry out a range of functions,...
Brain atlas aids CNS research
Researchers in the US have published the first raft of data from
the GENSAT project, designed to track the maze of connections
between cells in the CNS.
Cutting contamination in RNA studies
Agilent Technologies has introduced a new RNA Isolation kit
designed to remove up to 1,000 times more genomic DNA than
Adenoviral gene silencing
Galapagos Genomics has published details of its RNAi-based gene
silencing technology, based on adenovirus vectors, that is
effective in a range of cell types.
Epoch breaks Amersham deal
Amersham will no longer act as a distributor for Epoch Bioscience's
MGB Eclipse range of probe systems after failing to meet sales
targets, according to the latter company.
Cardinal Health buys Gala
Cardinal Health is to acquire 100 per cent ownership of protein
production specialist Gala Biotech for $15.5 million (€13.2m)in a
move to bolster its drug development services business.
Affymetrix set to ship human genome chip
Affymetrix is taking orders for a new one-chip product that offers
researchers the protein-coding content of the human genome on a
Mouse model for kidney stones
A mouse model for cystinuria type I, commonly known as kidney
stones, has been developed by German company Ingenium
Mouse genome array from Amersham
Amersham Biosciences has added a mouse genome product in its
CodeLink range, used for drug target identification, pathway
characterisation and drug effect predictions.
Inflammation and atrial fibrillation
Italian researchers suggest that patients with atrial fibrillation
may have a genetic predisposition linked to expression of
Merck buys into microarray market
Merck KGaA buys ProteoPlex in a move designed to shore up its
position in the emerging microarray market, estimated to reach $2
billion (€1.76bn) in 2008.
GSK signs up for ACLARA's eTag system
GSK is the latest company to sign a license for ACLARA Biosciences'
eTag Assay System, used in gene expression profiling studies.
New skin cancer gene located
Cancer Research UK scientists have found the location of a new gene
on chromosome 1 which pre-disposes people to skin cancer.
Genome on a chip from Applied Bio
Applied Biosystems has unveiled a gene expression analysis product
that allows researchers to conduct studies on the entire human
genome using a single microarray.
Tissue microarray use on the rise
There is a growing reliance on the use of tissue microarrays to
accelerate the examination of histological samples used in drug
discovery, according to a new report from BioInformatics.
deCODE starts screening programme in schizophrenia
Iceland's deCODE genetics has initiated high-throughput screening
on its Neuregulin 1 pathway targets in schizophrenia in
collaboration with partner Roche.
Scientists investigate oldest form of life on earth
Research into genomes of the natural world took a step forward this
week with the announcement from Diversa corporation that it is to
jointly collaborate with the US Department of Energy's Joint Genome
Institute (JGI) to discover...
A LEAP ahead
Specialists in cellular analysis Cyntellect this week announced the
issuance of a new patent covering the company's Laser Enabled
Analysis and Processing (LEAP) technology platform.
Aclara BioSciences, a US company involved in tools for drug
discovery, this week introduced new toxicology applications that
expand the capabilities of the eTag Assay System.
Genomics tech grows with drug target validation
Drug target validation has become the critical step in maintaining
profitability for the pharmaceutical industry, claims a new report
from market research company Business Communications. Drug
developers must accelerate identification...